Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05717439 · ClinicalTrials.gov registry record
Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD
A clinical trial of Major Depressive Disorder and PTSD, sponsored by Senseye.
- Completed
- Registry status
- 338
- Enrollment target
- 5
- Study locations
NCT05717439 is a study of Major Depressive Disorder and PTSD that has completed, run by Senseye. The registered enrollment target is 338 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (10% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT05717439, a study of Major Depressive Disorder and PTSD, has completed, sponsored by Senseye.
- COMPLETED
- Registry status
- 338 participants
- Enrollment target
- 5
- Study locations
Study Summary
The aim of this study is to obtain data on the feasibility of the Senseye Diagnostic Tool (DT) to assess the presence and severity of post-traumatic stress disorder (PTSD) symptoms. The study will also collect data on Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD) to aid in assessing the presence and severity of these disorders both for the purpose of discerning them from PTSD and determining the feasibility of diagnosing them independently.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CAPS-5-R
- DIAGNOSTIC_TEST Senseye DT
Study Locations (5)
Texas
- Future Search Trials - Dallas
- DHR Health Institute for Research and Development - Edinburg
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Idaho
- Velocity Clinical Research - Meridian
South Carolina
- Ralph H. Johnson VA Health Care System - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2024-07-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05717439
The ClinicalTrials.gov registry entry for NCT05717439 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (10% lower). The listed sponsor is Senseye, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which CAPS-5-R is the first listed.
NCT05717439 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Texas, Colorado, Idaho.
Frequently Asked Questions
What is clinical trial NCT05717439 about?
NCT05717439 is a clinical study titled "Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD". The aim of this study is to obtain data on the feasibility of the Senseye Diagnostic Tool (DT) to assess the presence and severity of post-traumatic stress disorder (PTSD) symptoms. The study will also collect data on Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD) to aid in a...
What is the current status of trial NCT05717439?
This trial is currently completed. The enrollment target is 338 participants. The study started on 2023-03-01. Estimated completion is 2024-07-25.
What conditions does trial NCT05717439 study?
This clinical trial studies the following conditions: Major Depressive Disorder, PTSD, Generalized Anxiety Disorder.
What interventions are being tested in trial NCT05717439?
The interventions under investigation include: CAPS-5-R (DIAGNOSTIC_TEST), Senseye DT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05717439?
This trial is sponsored by Senseye, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05717439 being conducted?
This trial has 5 study locations across Colorado, Idaho, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Taking Action for College Students
RECRUITING · NA
-
Neural Response to Inflammatory Challenge in Major Depressive Disorder
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.